EP 1225891 A2 20020731 - USE OF A BIS-PEROXOVANADIUM COMPOUND FOR THE TREATMENT OF IMMUNOSUPRESSED PATIENTS
Title (en)
USE OF A BIS-PEROXOVANADIUM COMPOUND FOR THE TREATMENT OF IMMUNOSUPRESSED PATIENTS
Title (de)
VERWENDUNG VON EINER BIS-PEROXOVANADIUM VERBINDUNG ZUR BEHANDLUNG VON IMMUNOSUPPRESSIVEN PATIENTEN
Title (fr)
UTILISATION D'UN INHIBITEUR DE LA PHOSPHOTYROSYLPHOSPHATASE DANS LE TRAITEMENT DE PATIENTS IMMUNODEPRIMES
Publication
Application
Priority
- CA 0001258 W 20001023
- US 16135499 P 19991026
Abstract (en)
[origin: WO0130325A2] The present invention provides a method for restoring the immune functions and the overall immune response by administration of a bis-peroxovanadium (bpV) compound, a potent class of phosphotyrosyl phosphatase inhibitors. The method can be utilized in treating individuals afflicted with immune disorders or for the treatment of patients suffering from infections caused by viruses that destroy the natural immune response, such as the human immunodeficiency virus (HIV). The bpV compound may be used in combination with various immunomodulators and/or antiviral agents. The present invention also relates to the use of such bpV compound for restoring the immune functions and the overall immune response in a patient in need of such a treatment.
IPC 1-7
IPC 8 full level
A61K 33/24 (2019.01); A61K 33/40 (2006.01)
CPC (source: EP US)
A61K 33/24 (2013.01 - EP US); A61K 33/40 (2013.01 - EP); A61P 31/18 (2017.12 - EP); A61P 37/04 (2017.12 - EP)
Citation (search report)
See references of WO 0130325A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0130325 A2 20010503; WO 0130325 A3 20020124; AU 1014101 A 20010508; CA 2389348 A1 20010503; EP 1225891 A2 20020731
DOCDB simple family (application)
CA 0001258 W 20001023; AU 1014101 A 20001023; CA 2389348 A 20001023; EP 00971189 A 20001023